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Abstract
Background: Social anxiety is both harmful and prevalent. It also currently remains among the most undertreated major mental
disorders, due, in part, to socially anxious individuals’ concerns about the stigma and expense of seeking help. The privacy and
affordability of computer-aided psychotherapy interventions may render them particularly helpful in addressing these concerns,
and they are also highly scalable, but most tend to be only somewhat effective without therapist support. However, a recent
evaluation of a new self-guided, 7-module internet-delivered cognitive behavioral therapy intervention called Overcome Social
Anxiety found that it was highly effective.
Objective: The initial evaluation of Overcome Social Anxiety revealed that it led to significant reductions in symptom severity
among university undergraduates. The aim of this study was to extend the results of the initial study and investigate their
generalizability by directly evaluating the intervention’s effectiveness among a general community sample.
Methods: While signing up for Overcome Social Anxiety, users consented to the usage of their anonymized outcome data for
research purposes. Before and after completing the intervention, users completed the Fear of Negative Evaluation Scale (FNE),
which we employed as the primary outcome measure. Secondary outcome measures included the Depression Anxiety Stress
Scales (DASS) and 2 bespoke questionnaires measuring socially anxious thoughts (Thoughts Questionnaire) and avoidance
behaviors (Avoidance Questionnaire).
Results: Participants who completed the intervention (102/369, 27.7%) experienced significant reductions in the severity of
their symptoms on all measures employed, including FNE (P<.001; Cohen d=1.76), the depression subscale of DASS (P<.001;
Cohen d=0.70), the anxiety subscale of DASS (P<.001; Cohen d=0.74), the stress subscale of DASS (P<.001; Cohen d=0.80),
the Thoughts Questionnaire (P<.001; Cohen d=1.46), and the Avoidance Questionnaire (P<.001; Cohen d=1.42).
Conclusions: Our results provide further evidence that Overcome Social Anxiety reduces the severity of social anxiety symptoms
among those who complete it and suggest that its effectiveness extends to the general community. The completion rate is the
highest documented for a fully automated intervention for anxiety, depression, or low mood in a real community sample. In
addition, our results indicate that Overcome Social Anxiety reduces the severity of symptoms of depression, physiological
symptoms of anxiety, and stress in addition to symptoms of social anxiety.
(J Med Internet Res 2019;21(1):e11566)   doi:10.2196/11566
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Social anxiety disorder has a high lifetime prevalence of
approximately 13% [1]. It causes considerable distress and
functional impairment, even at a subclinical level of severity
[2], and impacts both the private and professional lives of those
affected by it [3,4]. It is persistent in the absence of treatment
[5] and is related to other mental disorders such as mood and
substance disorders [6]. Yet, social anxiety remains one of the
most undertreated of all major mental disorders today [7].
Importantly, its relatively low treatment rate cannot be attributed
to any lack of empirically supported treatment methods; research
has shown that both psychotherapeutic treatments (eg, cognitive
behavioral therapy, CBT) and pharmaceutical treatments (eg,
selective serotonin reuptake inhibitors) for social anxiety are
effective [8,9]. Rather, financial constraints and concerns about
being judged or stigmatized for seeking help, among other
issues, represent major barriers to treatment for socially anxious
individuals [7].
Computerized cognitive behavioral therapy (CCBT), a promising
and increasingly popular treatment for anxiety and depression
[10], may be particularly useful in surmounting social anxiety’s
unique barriers to treatment, as it is more affordable and can be
accessed more privately than traditional psychotherapy. Most
computer-aided psychotherapy (CP) interventions (a category
of interventions including CCBT) involve some therapist
support, and the effectiveness of CP interventions is related to
the amount of therapist support their users receive [11,12].
Accordingly, self-guided CCBT interventions—those designed
to operate independently, without the necessity of therapist
support—tend to be less effective than those involving therapist
support [13].
Overcome Social Anxiety
A recent study suggests that a self-guided internet-delivered
cognitive behavioral therapy (ICBT; CCBT delivered via the
internet) intervention called Overcome Social Anxiety may
represent a notable exception to the tendency for self-guided
CCBT interventions to be less effective than those involving
therapist support [14]. The study—a randomized controlled trial
among undergraduate university students, which compared
Overcome Social Anxiety with a wait-list control
condition—revealed a between-groups effect size (Cohen
d=0.97) similar to the average between-groups effect size of 19
trials of computer-aided interventions with therapist support
found in a review (Cohen d=0.96) [11].
Overcome Social Anxiety arose from a program of research
exploring the common limitations of other CCBT interventions
[15] and was designed to address 5 such limitations in particular.
First, where many other interventions do not adequately
individualize treatment to individual participants’ needs,
Overcome Social Anxiety employs a series of questionnaires
to tailor each user’s treatment package to address their unique
symptoms and the contexts in which those symptoms typically
occur. Second, corrective feedback on important aspects of the
CBT process is often lacking from CCBT interventions;
Overcome Social Anxiety mitigates the need for corrective
feedback by providing example responses to help ensure that
users fully understand what they are required to do at each stage
of the treatment process (eg, challenging maladaptive thoughts
and designing behavioral experiments). Third, where some
interventions do not adequately address low adherence rates
[15], which remain common among CP interventions today
[16], Overcome Social Anxiety employs 2 mechanisms to
encourage users to make steady progress: (1) it hinders
procrastination by limiting users to a 6-month window to
complete the intervention and (2) it mitigates forgetfulness by
sending users automated reminders to continue their work on
the program following periods of inactivity. Fourth, although
research shows that therapist-client interaction is an important
aspect of successful CBT [17], it is by definition lacking from
stand-alone CCBT interventions. Overcome Social Anxiety
addresses this challenge by employing voice recordings of 2
clinical psychologists to guide users through the treatment
process, more closely mirroring a traditional course of
human-delivered therapy. A recent study found that the
patient-program alliance, similar to the therapeutic alliance, is
associated with greater adherence and more favorable clinical
outcomes in CCBT [18], indicating that such efforts at
improving how users relate to interventions themselves are
unlikely to be misguided. Finally, many other interventions
have failed to provide users with a sufficient dose of treatment
to effect lasting positive change [15], despite research attesting
to the importance of an appropriate dose of treatment to CBT’s
success [19]. Overcome Social Anxiety was designed to deliver
a more robust treatment package than many other programs and
includes all established elements of modern CBT.
Overcome Social Anxiety comprises an assessment battery and
7 core modules. The intervention begins with a
prequestionnaires module, which is designed both to take a
pretreatment measure of users’ symptom severity and to
individualize the treatment to each user. Module 1, Thinking
exercises, introduces users to the program and their virtual
psychologists, informs users of common cognitive errors, and
explains the relationship between cognitions, behaviors, and
emotions. Module 2, Challenging your thinking, presents users
with personally relevant anxious thoughts (based on
prequestionnaire responses) and asks users to challenge those
thoughts through writing exercises. In module 3, Creating your
model, users select symptoms and anxiety-inducing situations
and cognitions, which the intervention then uses to individualize
the treatment to users’ unique experiences of social anxiety.
This model is then applied to module 4, Behavioral experiments,
wherein users are guided through a series of behavioral
experiments to target safety behaviors and avoidance. Module
5, Challenge your thinking further, continues to help users adjust
their negative beliefs, with a particular emphasis on anger.
Module 6, Self-processing, targets biased attentional processes
through skills-based attention training [20] and rescripting of
faulty and negative imagery [21]. Module 7, Relapse prevention,
reviews the material covered in the first 6 core modules and
provides users with psychoeducation to help them maintain
treatment gains. Finally, users complete the postquestionnaires
module, which the program uses to create histograms to show
users the difference between their pre- and posttreatment
symptom severity. The program then provides users with an
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individualized PDF containing all program materials, which
users can employ to help maintain treatment gains into the
future.
Each module was designed to achieve a particular clinical goal
and not necessarily to be completed in a single sitting. Indeed,
some require substantially more time and effort than others. For
example, when users are taught how to change their thinking
in module 2, they are encouraged to target 1 thought they are
working on changing per day. Please see the initial trial [14]
for more detailed information about the content of the program
and Multimedia Appendix 1 for a screenshot.
The results of the initial trial indicate that the 5 design features
discussed above may be collectively very useful, potentially
contributing enough to bridge the effectiveness gap between
self-guided and therapist-assisted interventions. Overcome
Social Anxiety—if it is indeed as effective as the initial trial
suggests—may have important implications not only for
reducing the severity of symptoms and increasing the well-being
of people who struggle with social anxiety but also for the
development of future interventions.
Although the initial study was a randomized controlled trial
with high internal validity, it did not explicitly investigate the
generalizability of its findings to the general community of
individuals with social anxiety. The purpose of this study was
to attempt to replicate the findings of the initial trial with high
external validity by employing Overcome Social Anxiety’s
general user base as its sample. Our rationale for conducting
this study was that—to the extent that the intervention was found
to be similarly effective among its general user base as it was
among the initial trial’s student sample—consumers, mental
health professionals, researchers, and developers of future ICBT
interventions would be able to place more confidence in the
intervention’s effectiveness.
Hypothesis
We hypothesized that among those who completed all modules
of the intervention (including its prequestionnaires module, its
7 core modules, and its postquestionnaires module), referred to
throughout this study as completers, posttreatment scores on
the Fear of Negative Evaluation Scale (FNE) [22] would be
significantly lower than pretreatment scores. The results from
the initial trial [14], which also employed FNE and found a
large pretreatment-to-posttreatment effect size for that measure
(Cohen d=0.82), suggested that this difference could be large.
Methods
Participants
In this study, we retrospectively analyzed data from past users
of Overcome Social Anxiety. These data were automatically
collected from users between August 2012 and April 2018.
Thus, no new data collection was necessary. Our sample (n=369)
consisted of all former, paying users of Overcome Social
Anxiety. We excluded (1) those whose usage of the program
was ongoing as of April 2018, (2) the university undergraduates
who participated in the initial trial [14], and (3) all other users
who were given free access to the intervention (eg, through the
private practices of its creators).
A power analysis suggested that, for within-subjects
comparisons of pre- and posttreatment FNE scores, a sample
of 40 completers would have been required to achieve a power
level of 0.99 at the P<.01 level of significance, two-tailed,
assuming the effect size of Cohen d=0.82 found in the initial
trial [14]. Even given a conservative estimate of an effect half
this size (ie, Cohen d=0.41) for this study’s population, we
would have achieved a power level of 0.93 at the P<.01 level
of significance, two-tailed, with the 102 users who completed
the intervention.
All past and present users of Overcome Social Anxiety
consented to the collection, anonymization, and later analysis
of their data for research purposes during registration. The
protocol for this study was approved by the University of British
Columbia’s Behavioural Research Ethics Board (Human Ethics
Application ID: H16-00319).
Outcome Measures
Overcome Social Anxiety begins with a prequestionnaires
module, which is included both to individualize the course of
treatment to each user’s needs and to measure each user’s
pretreatment symptom severity. The intervention concludes
with a postquestionnaires module, which allows users to quantify
changes in the severity of their symptoms. Both these modules
contain 4 measures. First, they contain the FNE scale [22], a
well-validated measure of social anxiety symptoms [22,23].
The brief FNE scale, whose scores have been found to share a
Pearson correlation coefficient of .96 with the original FNE
(r=.96) [24], correlates with other measures of social anxiety
and yields significantly higher scores among those diagnosed
with social anxiety disorder than those without [25]. The FNE
comprises 30 statements (eg, “I worry that others will think I
am not worthwhile”) that respondents mark as true or false and
yields a total score between 0 and 30. Scores of 7 (1 SD below
the mean for a large student sample) and 8 (lower quartile) have
been recommended as cut-off scores to indicate low social
anxiety, whereas scores of 22 (1 SD above the mean) and 20
(upper quartile) have been recommended as cut-off scores to
indicate high social anxiety [23].
Second, both these modules include the Depression Anxiety
Stress Scales (DASS) [26], a 42-item questionnaire designed
to discriminate between depression (eg, “I felt sad and
depressed”), anxiety (eg, “I was aware of dryness of my
mouth”), and stress (eg, “I was in a state of nervous tension”),
despite their shared symptoms. Research has attested to its
reliability and validity [27,28].
Finally, these modules include 2 bespoke questionnaires, which
ask users about the frequency with which they experience 37
socially anxious thoughts (eg, “I can’t speak to authority
figures”) and avoid 23 anxiety-provoking situations (eg,
“Making small talk with strangers/colleagues”). The items on
these 2 questionnaires—titled the Thoughts Questionnaire and
the Avoidance Questionnaire, respectively—were retrieved
from a file audit of decades of clinical psychology practice with
individuals diagnosed with social anxiety. Both questionnaires
are scored on 5-point Likert scales and are intended to capture
the patterns of thinking and behavior characteristic of real
experience with social anxiety symptoms. Cronbach alphas for
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the Thoughts Questionnaire and the Avoidance Questionnaire
were .94 and .89, respectively. In our sample, participants’
scores on FNE were related to their scores on both bespoke
questionnaires, with Pearson correlation coefficients of .58
(n=369; P<.001) for the Thoughts Questionnaire and .36 (n=369;
P<.001) for the Avoidance Questionnaire.
Procedure
Users from around the world found Overcome Social Anxiety
independently and chose to sign up for US $149.99. The
intervention was advertised through Google Adwords between
August 2012 and August 2014, has received media coverage,
and has seen mention in blog posts, which likely helped users
to discover it. During registration, users consented to the use of
their data for research. After signing up, users first completed
the prequestionnaires module, consisting of FNE, DASS, the
Thoughts Questionnaire, and the Avoidance Questionnaire.
They then began working through the 7 core modules of the
program (see Figure 1 for content outline and the initial trial
[14] for details). On completing all the program’s core modules,
users responded to FNE, DASS, the Thoughts Questionnaire,
and the Avoidance Questionnaire again during the
postquestionnaires module. At the end of this module, they were
also asked to leave feedback for the creators of the intervention.
Users were given a limit of 6 months from the date of their
registration to complete the intervention. They were sent
automated emails reminding them to continue using the program
after 3, 7, 10, 14, 21, and 28 days of inactivity. On completing
each module, users were also sent automated emails
summarizing that module’s contents. As this study involved
only the retrospective analysis of data from past users of
Overcome Social Anxiety, there was no contact with participants
throughout the course of the study.
Analyses
This study’s primary dependent variable was
pretreatment-to-posttreatment change in the severity of social
anxiety symptoms, as measured by FNE. We selected FNE as
a primary measure because it is a well-established and validated
measure of social anxiety symptoms and because our other
measure of anxiety, the anxiety subscale of DASS, measures
primarily physiological symptoms of anxiety and does not
specifically measure social anxiety symptoms. However, we
also analyzed changes in scores on 5 secondary measures—the
3 factors of DASS, the Thoughts Questionnaire, and the
Avoidance Questionnaire. For each of these measures,
within-subjects t tests were conducted to determine whether
posttreatment scores differed from pretreatment scores among
users who completed the intervention.
We tested for attrition bias by exploring differences between
completers and noncompleters. Specifically, we conducted
between-subjects t tests to check for differences between
completers and noncompleters in age and pretreatment scores
on all questionnaire measures. We also conducted Chi-square
analyses for sex and whether users reported having previously
seen a therapist for anxiety, seen a therapist for other reasons,
or taken medication for anxiety. Finally, after imputing missing
posttreatment data from noncompleters using a last observation
carried forward approach, we conducted between-subjects t
tests to check for pretreatment-to-posttreatment changes in
symptoms on all outcome measures among all users, completers
and noncompleters alike.
At the end of the postquestionnaires module, completers were
asked to leave positive and negative feedback about the
intervention. Employing a conventional content analysis
approach [29] and QSR NVivo 11 software, we used both
qualitative methods (coding participants’ responses and grouping
them into themes) and quantitative methods (counting comments
reflecting each theme and calculating descriptive statistics) to
analyze participants’ responses [30]. Two researchers (KG—see
Acknowledgments below—and author HM) carefully read each
comment and collaboratively created a coding guide. KG used
this guide to code each response and then met HM again to
discuss potential inconsistencies in the application of the coding
guide to the analysis of participants’ comments. Finally, an
expert coder (author HH) conducted a final review of the coded
comments, counted comments reflecting each theme, and
calculated descriptive statistics.
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Figure 1. Flowchart of user progress.
Results
Program Usage
Of the 369 users who signed up for Overcome Social Anxiety
between August 2012 and April 2018, 102 users (102/369,
27.7%) fully completed the intervention. The number of users
who completed each module of the intervention is displayed in
Figure 1. The average time taken for completion of each module,
in minutes, was 14.70 for the prequestionnaires, 34.60 for
module 1, 83.70 for module 2, 43.10 for module 3, 103.72 for
module 4, 15.02 for module 5, 25.05 for module 6, 8.05 for
module 7, and 19.10 for the postquestionnaires. Completers
spent a mean of 5 hours and 34 min (SD 211 min) using the
intervention, whereas noncompleters spent a mean of 2 hours
and 11 min (SD 86 min). However, these data represent only
the amount of time users spent logged in to the intervention.
Important components of CBT, including homework exercises
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such as exposure activities, occur between sessions, and the
overall amount of time spent is likely to be considerably higher.
On average, completers logged in 25.06 times (SD 17.25) over
a period of 138.07 days (SD 126.07), whereas noncompleters
logged in 9.93 times (SD 8.14) over a period of 58.02 days (SD
83.27).
User Characteristics
Out of the 102 completers, 39 (38.2%) identified as female, 58
(56.9%) identified as male, and 5 (4.9%) did not report their
sex. The mean age of completers was 35.47 (SD 13.64). When
asked about their clinical history, many completers reported
having previously seen a therapist for anxiety (45/94, 48%),
seen a therapist for another reason (43/95, 45%), and taken
medication for anxiety (36/96, 38%). These data, in addition to
those of noncompleters, are displayed in Table 1. The most
common countries of residence users reported during registration
were the United States (105/369, 28.5%), the United Kingdom
(56/369, 15.2%), Australia (55/369, 15.0%), Iceland (30/369,
8.1%), and Canada (28/369, 7.6%). The remaining users were
spread across 25 other countries around the world (60/369,
16.3%) or did not report their countries of residence (35/369,
9.5%).
Pretreatment Questionnaire Scores
The mean pretreatment FNE score among completers was 25.91
(SD 3.99), indicating very high levels of social anxiety. This
score approached the FNE’s maximum score of 30 and exceeded
cut-off scores defining high anxiety (20 and 22) by a
considerable margin [23]. For DASS, completers had
pretreatment scores of 14.07 (SD 10.07) on the depression
subscale, 9.93 (SD 6.84) on the anxiety subscale, and 16.28 (SD
8.05) on the stress subscale. Finally, completers’ mean
pretreatment scores on the Thoughts Questionnaire and
Avoidance Questionnaire were 79.72 (SD 23.4) and 51.37 (SD
14.85), respectively.
Comparison of Completers and Noncompleters
A between-subjects t test revealed that completers had lower
scores than noncompleters on the anxiety subscale of DASS
(equal variances not assumed; t217.66=2.95; P=.003; Cohen
d=−0.33). Between-subjects t tests of DASS’s depression and
stress subscales, FNE, the Thoughts Questionnaire, the
Avoidance Questionnaire, and age revealed no further
differences between completers and noncompleters (all P s>.07).
In addition, Chi-square analyses revealed no differences between
completers and noncompleters in sex ratio or whether users
reported having previously seen therapists for anxiety, seen
therapists for other reasons, or taken medication for anxiety (all
P values> .15).
Effectiveness of the Intervention
C o m p l e t e r s  e x p e r i e n c e d  s i g n i f i c a n t
pretreatment-to-posttreatment reductions in symptom severity
on all measures employed: FNE (t101=13.61; P<.001; Cohen
d=1.76), the depression subscale of DASS (t101=7.42; P<.001;
Cohen d=0.70), the anxiety subscale of DASS (t101=8.24;
P<.001; Cohen d=0.74), the stress subscale of DASS (t101=9.57;
P<.001; Cohen d=0.80), the Thoughts Questionnaire (t101=16.47;
P<.001; Cohen d=1.46), and the Avoidance Questionnaire
(t101=15.40; P<.001; Cohen d=1.42). Demographic
characteristics and pretreatment questionnaire scores for all
users, in addition to posttreatment questionnaire scores and
symptom change analyses for completers, are summarized in
Table 1.
For each outcome measure, some completers reported a
worsening in symptom severity from pre- to posttreatment.
These changes were all less than 1 SD (ie, 1 pretreatment SD
among completers for each measure) in magnitude, except for
those of 3 (3/102, 3.0%) participants for FNE, 4 (4/102, 4.0%)
for the depression subscale of DASS, 1 (1/102, 1.0%) for the
anxiety subscale of DASS, and 1 (1/102, 1.0%) for the stress
subscale of DASS.
As discussed above in outcome measures, FNE threshold scores
of 20 and 22 have been recommended to distinguish between
high anxiety and moderate or low anxiety individuals [23].
According to these thresholds, 96 (96/102, 94.1%) or 90 (90/102,
88.2%) completers reported high anxiety before beginning the
clinical content of the intervention, whereas 33 (33/102, 32.4%)
or 28 (28/102, 27.5%) reported high anxiety after completing
it. One completer began the intervention below 1 of the
thresholds (with a score of 20) and ended it above that threshold
(with a score of 24). All other participants either remained in
the same category of anxiety or experienced a reduction in their
FNE score, which moved them past a threshold and into a lower
category of anxiety.
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Table 1. User characteristics and questionnaire scores.
Total (N=369)Noncompleters (n=267)Completers (n=102)Characteristic
User characteristicsa
137 (39.0)98 (38.4)39 (40.2)Female, n (%)
34.31 (12.42)33.88 (11.93)35.47 (13.64)Age, mean (SD)b
174 (50.9)129 (52.0)45 (47.9)Seen therapist for anxiety, n (%)
139 (40.6)96 (38.9)43 (45.3)Seen therapist for other reasons, n (%)
156 (45.5)120 (48.6)36 (37.5)Taken medication for anxiety, n (%)
Fear of negative evaluation
25.63 (4.78)25.53 (5.05)25.91 (3.99)Pretreatment, mean (SD)
——15.06 (8.32)Posttreatment, mean (SD)
Changec




15.72 (10.99)16.34 (11.28)14.07 (10.07)Pretreatment, mean (SD)
——7.57 (8.60)Posttreatment, mean (SD)
Changec




11.73 (7.93)12.42 (8.212)9.93 (6.84)Pretreatment, mean (SD)
——5.32 (5.64)Posttreatment, mean (SD)
Changec




17.63 (9.08)18.14 (9.40)16.28 (8.05)Pretreatment, mean (SD)
——10.01 (7.63)Posttreatment, mean (SD)
Changec




80.40 (23.57)80.66 (23.68)79.72 (23.40)Pretreatment, mean (SD)
——44.93 (24.17)Posttreatment, mean (SD)
Changec
——16.47 (101)t test (df)
——<.001P value
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Total (N=369)Noncompleters (n=267)Completers (n=102)Characteristic
——1.46Cohen d
Avoidance Questionnaire
52.08 (15.37)52.35 (15.59)51.37 (14.85)Pretreatment, mean (SD)
——29.54 (15.97)Posttreatment, mean (SD)
Changec
——15.40 (101)t test (df)
——<.001P value
——1.42Cohen d
aSome users did not respond to certain questions. The 5 rows beneath this heading display responses from 97 completers and 255 noncompleters who
reported their sex, 92 completers and 246 noncompleters who reported their age, 94 completers and 248 noncompleters who reported whether or not
they had previously seen a therapist for anxiety, 95 completers and 247 noncompleters who reported whether or not they had previously seen a therapist
for another reason, and 96 completers and 247 noncompleters who reported whether or not they had previously taken medication for anxiety. The
percentages given represent percentages of respondents, not percentages of participants overall.
bAge was measured by year of birth, and our statistics on users’ ages represent their ages at the end of the calendar years during which they began the
intervention.
cThis row displays the results of a within-subjects t test comparing completers’ pre- and posttreatment scores.
dDASS: Depression Anxiety Stress Scales.
Imputation of Missing Data
It has been suggested that where dropout rates exceed 20%—and
this study’s dropout rate (267/369, 72.4%) did so by far—“no
adequate recommendation [for replacing missing data] can be
provided” [31]. However, research has demonstrated that partial
completion of ICBT interventions for anxiety and depression
leads to symptom reduction [32], and noncompleters in our
sample spent an average of over 2 hours using Overcome Social
Anxiety, suggesting that noncompleters may have benefited
from the intervention. For this reason, imputation of missing
data from noncompleters using a last observation carried forward
approach may be conservative. A within-subjects t test
comparing pre- and posttreatment FNE scores for all users,
assuming no pretreatment-to-posttreatment change in FNE
scores for noncompleters, indicated that the program was
moderately effective in reducing symptoms among all users
(t368=8.95; P<.001; Cohen d=0.48). Even in the hypothetical
and unlikely event that noncompleters experienced an increase
in social anxiety symptoms equivalent to half an SD on FNE
(ie, a score increase of 2.52; Cohen d=0.5), our results would
show a small but statistically significant reduction in FNE scores
among all users (t368=3.08; P=.002; Cohen d=0.18).
Furthermore, within-subjects t tests comparing pre- and
posttreatment scores on secondary outcome measures—again,
assuming no change in score for noncompleters from pre- to
posttreatment—showed significant, small-to-moderate
reductions in symptom severity on all secondary outcome
measures: the depression subscale of DASS (t368=6.31; P<.001;
Cohen d=0.16), the anxiety subscale of DASS (t368=6.78;
P<.001; Cohen d=0.16), the stress subscale of DASS (t368=7.46;
P<.001; Cohen d=0.19), the Thoughts Questionnaire (t368=9.63;
P<.001; Cohen d=0.37), and the Avoidance Questionnaire
(t368=9.41; P<.001; Cohen d=0.35).
Acceptability of the Intervention
Analysis of user feedback identified 9 positive themes and 8
areas for improvement. These themes, the number of participants
whose comments reflected them, and examples of these
comments are displayed in Table 2. It is worth noting that
feedback was only obtained from users on their completion of
the program and that users were asked about both what they
liked and what they did not like about the intervention. Out of
102 completers, 35 users left comments. The mean number of
comments coded as positive feedback was 1.77 (SD 1.17),
whereas the mean number of comments coded as areas for
improvement was 0.80 (SD 0.83).
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Table 2. Feedback from completers.
n (%)Feedback theme
Positive feedback
26 (25.5)General praise (eg, I loved this program.) 
18 (17.6)Specific symptom improvement (eg, ...this program truly did help me overcome a lot of the thoughts I was having.) 
12 (11.8)Content quality (eg, ...shows deep understanding of the problems of social anxiety.) 
9 (8.8)Components (eg, ...I find the e book invaluable...) 
9 (8.8)Presentation (eg, Liked A variety of pictures, sound and interaction.) 
6 (5.9)Convenience or accessibility (eg, Good to be able to do things completely at your own speed.) 
3 (2.9)Cost (eg, Not too expensive.) 
3 (2.9)Privacy (eg, AI Therapy’s anonymous and confidential form of treatment has been wonderful...) 
2 (2.0)Ease of use (eg, Easy to use. Great format. Very user friendly.) 
Areas for improvement
10 (9.8)Components (eg, I found some of the content helpful, but there were some bits that I didn’t find help nor did it relate to me.) 
7 (6.9)Presentation (eg, ...I wish it was a little more visually interesting.) 
4 (3.9)Content quality (eg, Would be good for anxious teenagers, but somewhat too simple for adults.) 
2 (2.0)Research considerations (eg, ...questionnaires were a bit long.) 
2 (2.0)Technical problems (eg, Little bit glitchy on an iPad.) 
1 (1.0)Cost (eg, Not much more help provided than self-help books which cost a lot less.) 
1 (1.0)Specific lack of symptom improvement (eg, I liked it even though i dont feel much improvement in my overall case...) 
1 (1.0)Length (eg, ...it was a little ’longer’ than I expected due to having to go out and face our fears...) 
Discussion
Principal Findings
Our primary hypothesis was that those who completed the
intervention would experience a significant reduction in the
severity of their social anxiety symptoms, as measured by FNE
[22]. This hypothesis was clearly supported by our results. In
fact, the effect size for this reduction (Cohen d=1.76) was larger
than the mean uncontrolled pretreatment-to-posttreatment effect
size of human-delivered CBT for social anxiety found in a
meta-analysis (effect size=1.04) [33]. By comparison, although
this study lacked a control condition, participants in the waitlist
control condition of our initial trial experienced a mean
reduction in FNE scores of 0.46 (Cohen d=0.14) over a similar
length of time [14]. Social anxiety is widely considered to have
a chronic course, and clinical and epidemiological studies have
reported that it has a mean duration of 10 to 24 years [34]. Given
this typical time course of social anxiety, in combination with
the results for the waitlist control condition of our initial trial,
we infer that the reduction in severity of social anxiety
symptoms in this study is attributable primarily to the
intervention rather than to spontaneous remission.
Our results also show that those who completed the intervention
experienced reductions not only in the severity of social anxiety
symptoms, as measured by FNE, but also in the severity of
symptoms of depression, physiological symptoms of anxiety,
and stress, as measured by DASS, and self-reported socially
anxious thoughts and avoidance behaviors, as measured by the
Thoughts Questionnaire and the Avoidance Questionnaire.
Given that social anxiety is related to depression [35], general
anxiety [35], and stress [36] and the 2 bespoke questionnaires
measured social anxiety symptoms, these results were
unsurprising. Nevertheless, they were pronounced; according
to Cohen guidelines for interpreting Cohen d [37], all these
changes were large (Cohen d>0.8) except for the changes on
the depression and anxiety subscales of DASS, which were
medium (Cohen d>0.5) in magnitude. We must advise caution
in interpreting these results, however, as they exclude data from
noncompleters and there is no control condition with which to
compare them.
The completion rate (102/369, 27.7%) was high in comparison
with community completion rates of other self-guided CP
interventions. Data from community users show lower
completion rates than data from trials [16], and self-guided CP
interventions have lower completion rates than therapist-assisted
CP interventions [38]; it is, therefore, unsurprising that
community adherence to self-guided CP is typically low. For
example, the highest completion rate found in a recent review
examining community usage of self-guided CP interventions
for depression, anxiety, and mood enhancement was 19.5%
[16], and the intervention that achieved this completion rate,
CBT Psych, was actually an earlier version of Overcome Social
Anxiety targeted toward stuttering populations. Other research
has shown that for self-guided internet psychotherapy
interventions, over 90% of users withdraw after only 2 sessions
[39]. In comparison, less than one-third of users in our sample
(112/369, 30.4%) withdrew before completing the
prequestionnaires, module 1, and module 2, which together took
J Med Internet Res 2019 | vol. 21 | iss. 1 | e11566 | p.9http://www.jmir.org/2019/1/e11566/
(page number not for citation purposes)
McCall et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
users an average of 2 hours and 13 min. It should be noted,
however, that there is some experimental evidence suggesting
that adding a financial cost to ICBT interventions increases
adherence [32]. Some proportion of Overcome Social Anxiety’s
comparatively high adherence rate may, therefore, be attributable
to its cost. Indeed, it would appear reasonable to expect that
users who are willing to make financial sacrifices to access
ICBT interventions are also more willing to sacrifice the time
and effort necessary to complete those interventions, whereas
those who are less committed may tend to opt for free ICBT
instead.
Finally, user feedback was generally positive. For example, of
the 35 completers who left feedback, 26 (26/35, 74%) left
general praise and 18 (18/35, 51%) specifically stated that they
had experienced a reduction in symptom severity. However,
because feedback was solicited only at the end of the
intervention, users who enjoyed and benefited from the
intervention may be overrepresented, whereas users who did
not enjoy or benefit from it may have tended to drop out before
reaching the user feedback questions.
Limitations and Future Research
There remain a number of important questions for future
research to address. First, although it has been shown that a
therapist’s assistance increases adherence to CCBT [38],
therapist-assisted CP is not as scalable as self-guided CP. The
further development of mechanisms to improve adherence to
self-guided CP interventions remains an important avenue for
future research. Second, it is a limitation of this study that we
have no posttreatment data from noncompleters and therefore
cannot report changes in their symptom severity following their
partial completion of the intervention. Although past research
shows that partial completion of ICBT interventions is beneficial
[32], and some participants may indeed have ceased using the
intervention after experiencing a satisfactory reduction in the
severity of their symptoms, future research measuring symptoms
periodically over the course of the treatment would be required
to clarify the effects of partially completing Overcome Social
Anxiety. Third, the intervention’s apparent success cannot
currently be attributed to any particular elements of its design.
Overcome Social Anxiety was created to address 5 limitations
of other ICBT interventions, but it remains unclear which of
these limitations are most crucial for designers of future ICBT
interventions to address. Fourth, although Overcome Social
Anxiety has now been evaluated as an intervention for university
undergraduates [14] and members of its general user base, future
research would be required to evaluate the intervention in a
clinical setting or to compare its effectiveness with
human-delivered CBT. On a related note, although high FNE
scores among our participants indicate that many of them may
have met diagnostic criteria for social anxiety disorder, our lack
of diagnostic interviews leaves us unable to draw any
conclusions about the intervention’s efficacy among those who
did. Fifth, additional research exploring the predictors of
program completion and symptom reduction could be useful in
targeting the program toward those most likely to benefit from
it or in establishing a screening mechanism to help prospective
users decide whether it is an appropriate treatment for them. To
this end, given our finding that completers had lower scores
than noncompleters on the anxiety subscale of DASS, research
examining that measure as a predictor of program outcomes
could be considered. Sixth, the fact that the majority of users
were men is interesting as a number of studies have shown that
social anxiety is more prevalent among women [40]. Future
research could explore the possibility that men value the privacy
afforded by stand-alone ICBT programs more highly than
women do. Finally, there is currently no data indicating whether
and for what length of time users maintain reductions in
symptom severity following their completion of the intervention.
Conclusions
Overcome Social Anxiety was initially evaluated through a
randomized controlled trial, which indicated that the intervention
reduces the severity of social anxiety symptoms among
university undergraduates [14]. Although our study’s lack of a
control condition leaves us unable to draw causal inferences,
we believe that it is reasonable to suppose that a considerable
proportion of the pretreatment-to-posttreatment reduction in
symptom severity may be attributable to the intervention, as
this was a very large effect (Cohen d=1.76) and research shows
that social anxiety tends to be persistent when it remains
untreated [5]. Given this assumption, this study reinforces the
findings of the initial trial [14] in 4 ways. First, it supports the
finding that Overcome Social Anxiety is effective in reducing
the severity of social anxiety symptoms. Second, its high
external validity extends the initial trial’s results to indicate that
the intervention is highly effective among community users
who complete it. Third, it suggests that the intervention’s
benefits are not limited to reducing the severity of social anxiety
symptoms; the program appears to alleviate symptoms of
depression, physiological symptoms of anxiety, and stress
among its users as well. Finally, this study suggests that
Overcome Social Anxiety has a high completion rate compared
with other self-guided CP interventions. In summary, the results
of this study converge with those of the initial trial’s, attesting
to Overcome Social Anxiety’s effectiveness as a self-guided
ICBT intervention and providing further indication that future
interventions may be able to draw from elements of its design.
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